Disrupting the miRNA-mediated reduction of anti-apoptotic proteins such as FAIM, could represent a new neuroprotective strategy against neurodegenerative diseases such as Alzheimer’s or Parkinson’s. Here, FAIM is linked to Parkinson disease.